Literature DB >> 22526087

Effectiveness of cleaning of workplace cytotoxic surface.

Laetitia Minh Mai Lê1, Pierre Alain Jolivot, Hassane Sadou Yaye, André Rieutord, Agnès Bellanger, Dominique Pradeau, Séverine Barbault-Foucher, Eric Caudron.   

Abstract

PURPOSE: To minimize the risk of chronic occupational exposure of antineoplastic drugs, cleaning procedures must be evaluated. This study was conducted to compare the detergent efficiency of cleaning solutions (two hydro-alcoholic solutions, three disinfectants and two detergents) used in different cleaning protocols.
METHODS: The central surface of a stainless steel plate (30 × 50 cm) was exposed to a carboplatin solution equivalent to 105,100 ng of platinum. After cleaning according to a standardized protocol, residual platinum contaminations were assayed on 10 × 10 cm sections.
RESULTS: After standardized cleaning, the residual quantity of platinum on the surface of the deposit accounted for between 1.0 and >15 % of the initial deposit. Spread of contamination on the plate depended on the cleaning movement and was between 2.1 and 53.9 % of the total quantity on the plate. The two detergents were more efficient (2,793-4,780 ng/plate) than hydro-alcoholic solutions (>20,000 ng/plate). The efficacy of the disinfectant was intermediate (5,891-6,122 ng/plate for solutions and 15,360 ng/plate for pre-soaked gauze). The cleaning protocol was also important with better efficiency of 8 mL of cleaning solution for 1,500 cm(2) (versus 4 mL), sprayed directly on the plate (versus wiping) with no contact time (versus 5 min).
CONCLUSION: The efficacy of chemical decontamination of cytotoxic work surfaces depends not only on the cleaning solution used, but also on the cleaning protocol. It is necessary to adapt the protocol to the surface to clean and it must be standardized and validated. This work is an example of an experimental procedure to evaluate the efficacy of cleaning solutions and protocols used at a workstation after exposure to antineoplastic drugs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22526087     DOI: 10.1007/s00420-012-0769-1

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  18 in total

1.  Pilot study comparing the efficacy of two cleaning techniques in reducing environmental contamination with cyclophosphamide.

Authors:  Karine Touzin; Jean-François Bussières; Eric Langlois; Michel Lefebvre; Angélique Métra
Journal:  Ann Occup Hyg       Date:  2010-01-29

2.  Validation of cleaning procedures for highly potent drugs. I. Losoxantrone.

Authors:  J A Shea; W F Shamrock; C A Abboud; R W Woodeshick; L Q Nguyen; J T Rubino; J Segretario
Journal:  Pharm Dev Technol       Date:  1996-04       Impact factor: 3.133

3.  Chemical degradation of wastes of antineoplastic agents: cyclophosphamide, ifosfamide and melphalan.

Authors:  S Hansel; M Castegnaro; M H Sportouch; M De Méo; J C Milhavet; M Laget; G Duménil
Journal:  Int Arch Occup Environ Health       Date:  1997       Impact factor: 3.015

4.  Urinary cyclophosphamide assay as a method for biological monitoring of occupational exposure to cyclophosphamide.

Authors:  C T Evelo; R P Bos; J G Peters; P T Henderson
Journal:  Int Arch Occup Environ Health       Date:  1986       Impact factor: 3.015

5.  Degradation and inactivation of antitumor drugs.

Authors:  J A Benvenuto; T H Connor; D K Monteith; J L Laidlaw; S C Adams; T S Matney; J C Theiss
Journal:  J Pharm Sci       Date:  1993-10       Impact factor: 3.534

6.  Stability and inactivation of mutagenic drugs and their metabolites in the urine of patients administered antineoplastic therapy.

Authors:  D K Monteith; T H Connor; J A Benvenuto; E J Fairchild; J C Theiss
Journal:  Environ Mol Mutagen       Date:  1987       Impact factor: 3.216

7.  Postulating a dermal pathway for exposure to anti-neoplastic drugs among hospital workers. Applying a conceptual model to the results of three workplace surveys.

Authors:  H Kromhout; F Hoek; R Uitterhoeve; R Huijbers; R F Overmars; R Anzion; R Vermeulen
Journal:  Ann Occup Hyg       Date:  2000-10

8.  Low-level (PPB) determination of cisplatin in cleaning validation (rinse water) samples. II. A high-performance liquid chromatographic method.

Authors:  R Raghavan; M Burchett; D Loffredo; J A Mulligan
Journal:  Drug Dev Ind Pharm       Date:  2000-04       Impact factor: 3.225

9.  Validation of cleaning procedures for highly potent drugs. II. Bisnafide.

Authors:  J Segretario; S C Cook; C L Umbles; J T Walker; R W Woodeshick; J T Rubino; J A Shea
Journal:  Pharm Dev Technol       Date:  1998-11       Impact factor: 3.133

10.  Mutagenicity of urine from nurses handling cytostatic drugs, influence of smoking.

Authors:  R P Bos; A O Leenaars; J L Theuws; P T Henderson
Journal:  Int Arch Occup Environ Health       Date:  1982       Impact factor: 3.015

View more
  5 in total

1.  Comparison of Decontamination Efficacy of Cleaning Solutions on a Biological Safety Cabinet Workbench Contaminated by Cyclophosphamide.

Authors:  Apolline Adé; Laure Chauchat; Johann-François Ouellette Frève; Sébastien Gagné; Nicolas Caron; Jean-François Bussières
Journal:  Can J Hosp Pharm       Date:  2017-12-21

2.  Efficiency of four solutions in removing 23 conventional antineoplastic drugs from contaminated surfaces.

Authors:  Nicolas Simon; Nicolas Guichard; Pascal Odou; Bertrand Decaudin; Pascal Bonnabry; Sandrine Fleury-Souverain
Journal:  PLoS One       Date:  2020-06-22       Impact factor: 3.240

3.  Risks to health professionals from hazardous drugs in Iran: a pilot study of understanding of healthcare team to occupational exposure to cytotoxics.

Authors:  Abdol Ali Shahrasbi; Minoo Afshar; Farnaz Shokraneh; Faezeh Monji; Mahjabin Noroozi; Maryam Ebrahimi-Khojin; Seyed Farzam Madani; Mehdi Ahadi-Barzoki; Mehdi Rajabi
Journal:  EXCLI J       Date:  2014-05-09       Impact factor: 4.068

4.  A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study.

Authors:  Michèle Vasseur; Nicolas Simon; Chloé Picher; Camille Richeval; Marion Soichot; Luc Humbert; Christine Barthélémy; Sandrine Fleury-Souverain; Pascal Bonnabry; Bertrand Décaudin; Delphine Allorge; Pascal Odou
Journal:  PLoS One       Date:  2018-08-08       Impact factor: 3.240

5.  Occupational risks evaluation in a centralized antineoplastic agent preparation unit.

Authors:  Quentin Dubray; Taibou Diallo; Richard Loeuillet; Emilie Andre; Anne-Sophie Fauqueur; Sandrine Poil; Nathalie Thromas; Philippe-Henri Secretan; Salvatore Cisternino; Joël Schlatter
Journal:  SAGE Open Med       Date:  2019-07-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.